Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 08, 2021 07:00 ET | Source: Attralus, Inc

Attralus Closes $116 Million Series B Financing

- Proceeds to advance pipeline of transformational pan-amyloid removal (PAR) therapeutics into the clinic - Financing led by Logos Capital and included other leading public healthcare funds - ...
July 28, 2021 07:00 ET | Source: Attralus, Inc

Attralus Appoints Jake Bauer to Board of Directors

SOUTH SAN FRANCISCO, Calif., July 28, 2021 (GLOBE NEWSWIRE) -- Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to improve the lives of patients with...